Earlier onset of type 2 diabetes may signal a more aggressive disease course and distinct metabolic profile. A comparative analysis published in Diabetes Care evaluated how age at diagnosis influences glycemic and cardiometabolic progression over nearly eight years of follow-up.

The study included 802 participants from the U.S. Diabetes Prevention Program (mean age 52.6 years) and 146 participants from the Kerala Diabetes Prevention Program (mean age 47.7 years). Biomarkers assessed at diagnosis and study end included fasting plasma glucose, hemoglobin A1c, lipids, BMI, blood pressure, and estimated glomerular filtration rate. Linear and mixed-effects models evaluated associations between age at onset and biomarker changes over time.

Young-onset diabetes was associated with greater adiposity at diagnosis and follow-up, with minimal BMI change in the U.S. cohort. Fasting glucose and HbA1c levels were similar at onset across age groups but rose faster in younger-onset participants, a pattern stronger in the U.S. cohort. Kidney function measured by eGFR was higher in younger-onset groups, while HDL cholesterol and systolic pressure were lower. Older-onset adults showed a slight decline in systolic pressure during follow-up.

These findings show that type 2 diabetes developing at a younger age carries greater long-term metabolic vulnerability. Early and sustained intervention is essential to slow glycemic decline and reduce complications.